Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 29 2021 - 8:02AM
Edgar (US Regulatory)
UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of March 2021
Commission File Number: 001-39545
Orphazyme A/S
(Translation of registrant’s name into English)
Ole Maaløes Vej 3, DK-2200
Copenhagen N
Denmark
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INCORPORATION BY REFERENCE
This Report on Form 6-K (the “Report”) and Exhibit 99.1 to this Report are hereby expressly incorporated by reference into the registrant’s registration statement on Form S-8 (File No. 333-249407) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently furnished.
EXHIBIT LIST
Exhibit
|
|
Description
|
99.1
|
|
Company announcement dated March 29, 2021
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Orphazyme A/S
|
|
|
|
|
Date: March 29, 2021
|
|
|
|
By:
|
|
/s/ Anders Vadsholt
|
|
|
|
|
|
|
Name
|
|
Anders Vadsholt
|
|
|
|
|
|
|
Title:
|
|
Interim Chief Executive Officer and Chief Financial Officer
|
Orphazyme A S (CE) (USOTC:OZYMF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Orphazyme A S (CE) (USOTC:OZYMF)
Historical Stock Chart
From Aug 2023 to Aug 2024